We developed a novel nomogram for predicting outcomes of salvage radiation therapy (sRT) after prostate-specific membrane antigen positron emission tomography/computed tomography for patients with biochemical recurrence of prostate cancer after radical prostatectomy. This evidence concerns the gene FOLH1 and prostate carcinoma.